AbbVie easily beat third-quarter expectations and raised its earnings outlook for the year. AbbVie stock rose Wednesday.

The post AbbVie Has A New Cash Cow As Humira Bows To Skyrizi In Third-Quarter Beat appeared first on Investor’s Business Daily.